ESMO

mRNA Covid-19 vaccines may boost cancer immunotherapy effectiveness
Clinical Trials Arena
Tue, 10/1/24 - 10:42 am
MRNA
vaccines
lung cancer
ESMO
COVID-19
ESMO-2024: Enhertu to eclipse the standard of care in HER2+ breast cancer with brain metastases
Clinical Trials Arena
Tue, 09/17/24 - 11:20 am
ESMO
breast cancer
Daiichi Sankyo
Enhertu
metastatic breast cancer
clinical trials
ESMO 2024: Eli Lilly brings the competition to Novartis with new results in mCRPC
Clinical Trials Arena
Tue, 09/17/24 - 11:13 am
Eli Lilly
ESMO
lutetium zadavotide guraxetan
Astellas
Janssen
metastatic castration-resistant prostate cancer
Kairos goes public with $6M IPO to fund trials of lead cancer drug
Fierce Biotech
Tue, 09/17/24 - 10:54 am
ESMO
Kairos Therapeutics
IPOs
ESMO: Pfizer sees weight gain in cancer patients, aims to enter phase 3 in 2025
Fierce Biotech
Tue, 09/17/24 - 09:57 am
Pfizer
ESMO
cancer wasting
clinical trials
ponsegromab
ESMO: Bayer hopes to expand Nubeqa's prostate cancer reach with chemo-free regimen
Fierce Pharma
Mon, 09/16/24 - 09:58 am
ESMO
Bayer
Nubeqa
prostate cancer
ESMO: Jazz HER2 bispecific posts 59% survival at 30 months in gastric cancer
Fierce Biotech
Mon, 09/16/24 - 09:50 am
Jazz Pharma
zanidatamab
gastroesophageal cancer
ESMO
ESMO 2024: Regeneron’s melanoma combo therapy benefit continues beyond two years
Clinical Trials Arena
Mon, 09/16/24 - 09:46 am
ESMO
Regeneron
melanoma
clinical trials
fiablimab
ESMO: J&J cues up phase 3 for Rybrevant in colorectal cancer
Pharmaphorum
Mon, 09/16/24 - 09:45 am
ESMO
JNJ
Rybrevant
colorectal cancer
ESMO: Bristol Myers axes Immatics' bispecific after $150M bet
Fierce Biotech
Mon, 09/16/24 - 09:44 am
Bristol Myers Squibb
Immatics
bispecifics
IMA401
ESMO
ESMO: Despite checkered past, Merck's Keytruda-Lenvima pairing looks to change practice in liver cancer subtype
Fierce Pharma
Sun, 09/15/24 - 06:30 pm
ESMO
Merck
Eisai
Keytruda
Lenvima
liver cancer
TIGIT drug from iTeos shrinks lung tumors in trial
BioPharma Dive
Sun, 09/15/24 - 06:28 pm
ESMO
iTeos Therapeutics
Tigit
GSK
lung cancer
belrestotug
ESMO: Even after unique trial win, Incyte CEO views PD-1 drug Zynyz as pipeline aide
Fierce Pharma
Sun, 09/15/24 - 06:27 pm
Incyte
Zynyz
ESMO
ESMO: AstraZeneca's Imfinzi extends life in bladder cancer type. Will FDA push back on its perioperative trial design?
Fierce Pharma
Sun, 09/15/24 - 06:22 pm
ESMO
AstraZeneca
Imfinzi
bladder cancer
ESMO: Despite positive trial, Merck's Welireg still comes up short in overall survival
Fierce Pharma
Fri, 09/13/24 - 11:12 am
Merck
Welireg
renal cell carcinoma
Novartis
Afinitor
ESMO
clinical trials
ESMO: Moderna’s mRNA solid tumour vaccine shows early promise
Clinical Trials Arena
Fri, 09/13/24 - 11:04 am
Moderna Therapeutics
MRNA
vaccines
solid tumors
ESMO
ESMO: AstraZeneca stands by Truqap despite surprise breast cancer flop
Fierce Pharma
Fri, 09/13/24 - 11:00 am
AstraZeneca
ESMO
FDA
Truqap
Novartis Builds Case for Earlier Prostate Cancer Treatment with Phase III Data
BioSpace
Tue, 10/24/23 - 09:54 am
ESMO
Novartis
prostate cancer
Pluvicto
radiopharmaceuticals
ESMO: AstraZeneca-Daiichi get clarity on patient deaths for Enhertu follow up Dato-DXd, survival data still unclear
Fierce Biotech
Mon, 10/23/23 - 05:22 pm
ESMO
Daiichi Sankyo
AstraZeneca
Enhertu
patient deaths
clinical trials
non-small cell lung cancer
Merck, BMS Score Separate Late-Stage Victories in Bladder Cancer at ESMO
BioSpace
Mon, 10/23/23 - 05:15 pm
ESMO
Merck
Bristol Myers Squibb
bladder cancer
PD-1 inhibitors
Keytruda
Padcev
Opdivo

Pages